STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G] Icad Inc SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary

THE GOLDMAN SACHS GROUP, INC. and Goldman Sachs & Co. LLC filed a Schedule 13G disclosing beneficial ownership of 1,452,580 shares of ICAD, Inc. common stock, representing 5.3% of the class. The filing shows shared voting and shared dispositive power over those shares and reports sole voting and dispositive power as 0. The statement affirms the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. A joint filing agreement and an exhibit identify Goldman Sachs & Co. LLC as a subsidiary and as a broker-dealer and registered investment adviser.

Positive
  • Goldman Sachs reports beneficial ownership of 1,452,580 ICAD shares, equal to 5.3% of the common stock.
  • Shared voting and shared dispositive powers over the reported shares are disclosed, with sole powers reported as 0.
  • The filing certifies the holdings are passive—acquired and held in the ordinary course and not to change or influence control.
Negative
  • None.

Insights

TL;DR: Goldman Sachs reports a passive 5.3% stake in ICAD with shared voting/dispositive power; disclosure is material but non-activist.

The filing reports 1,452,580 shares (5.3%) beneficially owned with shared voting and shared dispositive power and no sole powers. The Schedule 13G includes an express certification that the position is held in the ordinary course of business and not to influence control, indicating passive intent. For investors, the development is material as a >5% holder disclosure, but it does not indicate an active governance or control strategy.

TL;DR: Schedule 13G shows passive ownership and a joint filing; governance implications are limited absent further disclosures.

The filing attaches a Joint Filing Agreement and identifies Goldman Sachs & Co. LLC as a subsidiary that may be the owner and as a broker-dealer and investment adviser. The reported structure—parent holding company and subsidiary broker/adviser—clarifies reporting responsibility but, combined with the passive certification, suggests limited immediate governance impact. Any change to this position or a switch to an active filing (e.g., Schedule 13D) would be materially different for corporate governance.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



THE GOLDMAN SACHS GROUP, INC.
Signature:Name: AMEEN SOETAN
Name/Title:Attorney-in-fact
Date:07/17/2025
GOLDMAN SACHS & CO. LLC
Signature:Name: AMEEN SOETAN
Name/Title:Attorney-in-fact
Date:07/17/2025
Exhibit Information

EXHIBIT (99.1) JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Common Stock, $0.01 par value, of ICAD, INC. and further agree to the filing of this agreement as an Exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement on Schedule 13G. Date: 07/17/2025 THE GOLDMAN SACHS GROUP, INC. By:/s/ AMEEN SOETAN ---------------------------------------- Name: AMEEN SOETAN Title: Attorney-in-fact GOLDMAN SACHS & CO. LLC By:/s/ AMEEN SOETAN ---------------------------------------- Name: AMEEN SOETAN Title: Attorney-in-fact EXHIBIT (99.2) ITEM 7 INFORMATION The securities being reported on by The Goldman Sachs Group, Inc. ("GS Group"), as a parent holding company, are owned, or may be deemed to be beneficially owned, by Goldman Sachs & Co. LLC ("Goldman Sachs"), a broker or dealer registered under Section 15 of the Act and an investment adviser registered under Section 203 of the Investment Advisers Act of 1940. Goldman Sachs is a subsidiary of GS Group.

FAQ

How many ICAD (ICAD) shares does Goldman Sachs report owning?

1,452,580 shares, representing 5.3% of ICAD common stock as reported in the Schedule 13G.

Does the Schedule 13G for ICAD state Goldman Sachs intends to influence control?

No; the filing certifies the securities were acquired and are held in the ordinary course of business and not to change or influence control of the issuer.

Which entities filed the Schedule 13G for ICAD?

The filing lists The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC as reporting persons.

What voting and dispositive powers are reported by Goldman Sachs for ICAD?

The filing reports 0 sole voting power, 1,452,580 shared voting power, 0 sole dispositive power, and 1,452,580 shared dispositive power.

Is there a joint filing agreement or subsidiary identification in the ICAD filing?

Yes; a Joint Filing Agreement (Exhibit 99.1) is attached and Exhibit 99.2 identifies Goldman Sachs & Co. LLC as a subsidiary and as a broker-dealer and registered investment adviser.
Icad Inc

NASDAQ:ICAD

ICAD Rankings

ICAD Latest News

ICAD Latest SEC Filings

ICAD Stock Data

105.77M
25.96M
5.51%
31.44%
0.85%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
NASHUA